Shoulder injury linked to vaccine administration (SIRVA), is a well-known but underreported problem phenomenon within the medical literature. It is defined as shoulder pain and/ or decreased range of motion subsequent to the receipt of a vaccination intended for intramuscular administration within the upper arm. It's hypothesized to ensue when vaccination is inadvertently injected into the shoulder joint or subdeltoid bursa, triggering an inflammatory cascade that damages the surrounding structures (1). It has been seen following tetanus, pneumococcus, and papillomavirus vaccinations, and has been recorded more frequently with influenza vaccinations due to their widespread utilization (2). In the wake of a pandemic that necessitated widespread vaccination campaigns on a global scale, SIRVA has emerged as a subject of significant concern. A spectrum of shoulder pathologies like subacromial and subdeltoid bursitis ,supraspinatus tendinitis, massive shoulder effusion and synovitis, calcific tendinitis, Parsonage-Turner syndrome, Quadrilateral space inflammation are reported afterward. (3,4). We want to mention individuals who presented with the complaint of shoulder pain to our outpatient clinic between January and June 2022, among 1352 patients documented through international classification of diseases codes related to shoulder pain, a subset of 14 patients have reported an onset of shoulder pain subsequent to receiving the COVID-19 vaccine. Eight out of 14 patients were male and the mean age was 51.7 years. All of the patients had left shoulder involvement. Three patients had limited shoulder range of motion in addition to shoulder pain. The mean and standard deviation of pain intensity